Skip to content

Cardiovascular

ACE Inhibitors

Explore interaction information for ACE Inhibitors and their listed medicines, including Enalapril, Lisinopril, and Captopril.

1 supplements in this library have a recorded interaction with this medication

Dangerous combinations

Supplements recorded as risky with this medication1 listed

Highest severity first

  1. SupplementsSea Moss (Irish Moss)TheoreticalCaution

    ACE Inhibitors can increase potassium levels, and the potassium in sea moss may add to the risk of hyperkalemia.

    Where the evidence comes from

    • Reference knowledge

    Confidence

    confidence 60/100

    Open Sea Moss (Irish Moss)
    →
Trade names
Enalapril, Lisinopril, Captopril, Ramipril, Perindopril, Benazepril
family
antihypertensives

Full write-up

What is it

ACE Inhibitors are cardiovascular medicines in the antihypertensives family, generally used to manage high blood pressure. This group includes Enalapril, Lisinopril, Captopril, Ramipril, Perindopril, and Benazepril.

This page is an educational reference for considering possible interactions with other products, including Sodium Bicarbonate, Sea Moss (Irish Moss), Beetroot Extract, Potassium, and Iodine. Anyone with a medical condition should consult a clinician about their individual medicines and products.

What interacts with it

The main concern across these interactions is potassium balance. ACE inhibitors reduce aldosterone secretion, which decreases renal potassium excretion. Adding Potassium can therefore cause potassium to accumulate, potentially leading to life-threatening hyperkalemia with cardiac arrhythmias.

Several other supplements may add to this risk through their potassium content or effects on potassium handling. Beetroot Extract and Sea Moss (Irish Moss) may increase potassium exposure when combined with ACE inhibitors. High-dose potassium iodide or concentrated Iodine preparations may also contribute to hyperkalemia, with greater concern in people with renal impairment or those using other potassium-retaining therapies.

Sodium Bicarbonate presents a different potassium-related concern. It can alter potassium balance, and bicarbonate-induced alkalosis drives potassium into cells. This may produce unpredictable potassium shifts and potentially mask the risk of hyperkalemia associated with ACE inhibitors.

These combinations warrant review with a prescriber or pharmacist, especially when kidney function is impaired, another potassium-retaining therapy is used, or a concentrated supplement preparation is involved. No combination in this group is identified as a useful pairing with ACE inhibitors.

Diatelos provides general wellness information based on published research. It is not medical advice. Talk to a clinician before starting any new supplement or practice, especially if you have a health condition, are pregnant, or take medication.